Updates are available Correction dated 2024-05-18
Click to view Correction: https://doi.org/10.1007/s11899-024-00734-x
-
Authors
Kewan, Tariq
Stahl, Maximillian
Bewersdorf, Jan Philipp
Zeidan, Amer M.
- License Information
-
More Information
Article History
Accepted: 20 March 2024
First Online: 18 April 2024
Change Date: 18 May 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11899-024-00734-x
Declarations
:
: Maximilian Stahl consulted for Curis Oncology and Boston Consulting; served on the advisory board for Novartis and Kymera, GSK, Rigel, Sierra Oncology; and participated in GME activity for Novartis, Curis Oncology, Haymarket Media and Clinical care options (CCO).
: This article does not contain any studies with human or animal subjects performed by any of the authors.
